Shimodaira Hideki 下平秀樹

… Alternative Names

Hideki Shimodaira 下平秀樹

SHIMODAIRA Hideki 下平秀樹

Less

Researcher Number	70373214
Affiliation (Current)	2025: 東北医科薬科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2018 – 2023: 東北医科薬科大学, 医学部, 教授 2014 – 2016: 東北大学, 加齢医学研究所, 准教授 2009 – 2011: Tohoku University, 病院, 講師 2007 – 2008: 東北大学, 加齢医学研究所, 助教 2005 – 2006: 東北大学, 病院・助手 2005: TOHOKU UNIVERSITY HOSPITAL, RESEARCH ASSOCIATE, 病院, 助手 2004: 宮城県立がんセンター(研究所), 薬物療法学部, 副主任研究員
Review Section/Research Field	Principal Investigator Gastroenterology / Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 56040:Obstetrics and gynecology-related / Experimental pathology Except Principal Investigator Medium-sized Section 49:Pathology, infection/immunology, and related fields / Biological Sciences
Keywords	Principal Investigator がんゲノム医療 / バリアント / 大腸癌 / メチル化 / p16 / CDK4/6阻害薬 / CDKN2A / 乳癌 / 卵巣癌 / BRCA … More / 機能評価 / PRAP阻害薬 / PARP阻害薬 / BRCA1 / Apoptosis / Drug response / DNA damage / DNA mismatch repair / アポトーシス / 抗癌剤感受性 / DNA損傷 / DNAミスマッチ修復 / 抗VEGF抗体 / CpGアイランドメチル化 / バイオマーカー / がん薬物療法 / CpG アイランド / エピジェネティクス / 下部消化管学 … More Except Principal Investigator 炎症 / コアフコース / 免疫グロブリンG / Fut8 / IgG / 糖鎖 / MLH1 / 機能解析 / 変異 / MYH / TP53 / BRCA1 / p53 / 腫瘍関連遺伝子 / がん抑制遺伝子 / がん関連遺伝子 Less

Elucidation of molecular mechanism for IgG levels regulated by L-fucose
- Principal Investigator
  
  顧建国
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 49:Pathology, infection/immunology, and related fields
- Research Institution
  Tohoku Medical and Pharmaceutical University
Functional assay to estimate the significance of variants in CDKN2A gene detected in cancer genome testingPrincipal Investigator
- Principal Investigator
  
  下平秀樹
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tohoku Medical and Pharmaceutical University
Biological analyses of BRCA1 gene missense variants for application to cancer genome medicinePrincipal Investigator
- Principal Investigator
  
  Hideki Shimodaira
- Project Period (FY)
  2018 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tohoku Medical and Pharmaceutical University
Significance of CIMP as a biomarker for chemotherapy in colorectal cancerPrincipal Investigator
- Principal Investigator
  
  Shimodaira Hideki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Tohoku University
Development of predictive marker of drug therapy for colorectal cancer by epigenetic analysis of circulating DNAPrincipal Investigator
- Principal Investigator
  
  SHIMODAIRA Hideki
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Tohoku University
Development of functional assays for tumor-related genes
- Principal Investigator
  
  ISHIOKA Chikashi
- Project Period (FY)
  2005 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Tohoku University
Function of DNA mismatch repair system in the signal transduction of DNA damage responsePrincipal Investigator
- Principal Investigator
  
  SHIMODAIRA Hideki
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Experimental pathology
- Research Institution
  TOHOKU UNIVERSITY
  Miyagi Cancer Center Research Institute

[Book] 遺伝性腫瘍学入門　遺伝性腫瘍の基礎知識　「免疫チェックポイント阻害薬」2022
- Author(s)
  （分担執筆）下平秀樹
- Total Pages
  392
- Publisher
  メディカルドウ
- ISBN
  9784909508164
- Data Source
  KAKENHI-PROJECT-21K07248
[Book] 遺伝性腫瘍学入門　遺伝性腫瘍の基礎知識　「免疫チェックポイント阻害薬」2021
- Author(s)
  （分担執筆）下平秀樹
- Total Pages
  392
- Publisher
  メディカルドウ
- ISBN
  9784909508164
- Data Source
  KAKENHI-PROJECT-18K09270
[Book] 新臨床腫瘍学（改訂第6版）2021
- Author(s)
  日本臨床腫瘍学会, （分担執筆）下平秀樹
- Total Pages
  792
- Publisher
  南江堂
- ISBN
  9784524227396
- Data Source
  KAKENHI-PROJECT-21K07248
[Book] 高齢者がん治療エビデンス＆プラクティス2021
- Author(s)
  滝口裕一、礒部　威、津端由佳里　（分担執筆）下平秀樹
- Total Pages
  248
- Publisher
  南江堂
- ISBN
  9784524228218
- Data Source
  KAKENHI-PROJECT-21K07248
[Book] 新臨床腫瘍学　がん薬物療法専門医のために　改訂第6版　「遺伝性腫瘍」日本臨床腫瘍学会編2021
- Author(s)
  日本臨床腫瘍学会, （分担執筆）下平秀樹
- Total Pages
  757
- Publisher
  南江堂
- ISBN
  9784524227396
- Data Source
  KAKENHI-PROJECT-18K09270
[Book] 高齢者がん治療　エビデンス＆プラクティス「食道がん」2021
- Author(s)
  滝口裕一、礒部　威、津端由佳里　（分担執筆）下平秀樹
- Total Pages
  233
- Publisher
  南江堂
- ISBN
  9784524228218
- Data Source
  KAKENHI-PROJECT-18K09270
[Book] 遺伝性大腸癌診療ガイドライン 2020年版2020
- Author(s)
  大腸癌研究会編　（作成委員；下平秀樹）
- Total Pages
  152
- Publisher
  金原出版
- ISBN
  9784307204156
- Data Source
  KAKENHI-PROJECT-18K09270
[Book] 次世代のがん治療薬・診断のための研究開発2016
- Author(s)
  下平秀樹
- Total Pages
  400
- Publisher
  技術情報協会
- Data Source
  KAKENHI-PROJECT-26460958
[Book] がん薬物療法時の腎障害診療ガイドライン2016
- Author(s)
  下平秀樹
- Total Pages
  46
- Publisher
  ライフサイエンス出版
- Data Source
  KAKENHI-PROJECT-26460958
[Book] 新臨床腫瘍学2015
- Author(s)
  日本臨床腫瘍学会編集、石岡千加史、河野隆志、稲沢譲治、大場雄介、曽和義弘、大塚和令、福井忠久、笹原由理子、高橋雅信、高橋信、加藤俊介、高野利実、佐治重衡、上野誠、松本光史、伊藤薫樹、石澤賢一、高橋昌宏、下平秀樹　他
- Total Pages
  738
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-26460958
[Book] 家族性腫瘍2015
- Author(s)
  石岡千加史、富田尚裕、野水整、吉田輝彦、宇都宮譲二、福島義光、山内泰子、水谷修紀、谷内江昭宏、東元健、福岡みずき、玉井裕也、田中潔、向井徳男、久保宜明、池田史圭、鈴木眞一、柴田浩行、小峰啓吾、高橋雅信、下平秀樹　他
- Total Pages
  607
- Publisher
  日本臨床
- Data Source
  KAKENHI-PROJECT-26460958
[Book] 分子標的治療薬その他の開発中の小分子物質Apoptosis促進剤、mTOR阻害剤、サリドマイド、レナリドマイド、その他2009
- Author(s)
  下平秀樹
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 20222023
- Author(s)
  Ando Yuichi、Nishiyama Hiroyuki、Shimodaira Hideki、et al.
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 28 Issue: 10 Pages: 1315-1332
- DOI
  10.1007/s10147-023-02382-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07248, KAKENHI-PROJECT-22K08350, KAKENHI-PROJECT-22K08357, KAKENHI-PROJECT-18K09270, KAKENHI-PROJECT-20H03575
[Journal Article] 抗がん薬による腎障害：病態と対策2022
- Author(s)
  下平秀樹
- Journal Title
  
  腎と透析
  
  Volume: 92 Pages: 599-603
- Data Source
  KAKENHI-PROJECT-21K07248
[Journal Article] 抗がん薬による腎障害：病態と対策2022
- Author(s)
  下平秀樹
- Journal Title
  
  腎と透析
  
  Volume: 92 Pages: 599-603
- Data Source
  KAKENHI-PROJECT-18K09270
[Journal Article] Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial2022
- Author(s)
  Yoshioka T, Takahashi M, Sakamoto Y, Okita A, Fukui T, Murakawa Y, Shindo Y, Imai H, Ohori H, Shirota H, Chiba N, Sasahara YI, Nomura T, Fukushima N, Yamaguchi T, Shimodaira H, Ishioka C.
- Journal Title
  
  Anticancer Res.
  
  Volume: 126 Issue: 4 Pages: 2009-20015
- DOI
  10.21873/anticanres.15680
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07657, KAKENHI-PROJECT-18K09270, KAKENHI-PROJECT-21K07248
[Journal Article] Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.2021
- Author(s)
  2.Takahashi M，Sakamoto Y，Ohori H，Tsuji Y，Kuroki M，Kato S，Otsuka K，Komine K，Takahashi M，Takahashi S，Shirota H，Ouchi K，Takahashi Y，Imai H，Shibata H，Yoshioka T，Tanaka M，Yamaguchi H，Yamaguchi T，Shimodaira H，Ishioka C.
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 88 Issue: 3 Pages: 393-402
- DOI
  10.1007/s00280-021-04277-3
- NAID
  120007169385
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07657, KAKENHI-PROJECT-18K09270, KAKENHI-PROJECT-21K07248
[Journal Article] Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203).2021
- Author(s)
  Takahashi M, Sakamoto Y, Otsuka K, Kanbe M, Ohori H, Shindo Y, Honda H, Saijo K, Ouchi K, Murakawa Y, Takahashi H, Kawai S, Tanaka Y, Yamaguchi T, Shimodaira H, Yoshioka T, Ishioka C.
- Journal Title
  
  Tohoku J Exp Med.
  
  Volume: 254 Issue: 1 Pages: 49-55
- DOI
  10.1620/tjem.254.49
- NAID
  130008045451
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K09270, KAKENHI-PROJECT-21K07248
[Journal Article] 特集　がん領域診療ガイドラインのアップデート　「大腸がん」2021
- Author(s)
  下平秀樹
- Journal Title
  
  腫瘍内科
  
  Volume: 28 Pages: 617-621
- Data Source
  KAKENHI-PROJECT-18K09270
[Journal Article] がんの転移再発予防2020
- Author(s)
  下平秀樹、工藤千枝子
- Journal Title
  
  産科と婦人科
  
  Volume: 増刊号 Pages: 200-202
- Data Source
  KAKENHI-PROJECT-18K09270
[Journal Article] Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study2018
- Author(s)
  Kato S, Imai H, Gamoh M, Takahata T, Ohori H, Yasuda K, Niitani T, Murakawa Y, Amagai K, Isobe H, Shindo Y, Kuroki M, Sakamoto Y, Shimodaira H, Yoshioka T, Ishioka C.
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 245 Issue: 1 Pages: 21-28
- DOI
  10.1620/tjem.245.21
- NAID
  130006733224
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08798, KAKENHI-PROJECT-18K09270
[Journal Article] Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey.2018
- Author(s)
  Oishi T, Sato K, Morita T, Mack JW, Shimodaira H, Takahashi M, Takahashi S, Inoue A, Murakawa Y, Kawahara M, Ishioka C, Miyashita M.
- Journal Title
  
  Jpn J Clin Oncol.
  
  Volume: 48 Issue: 10 Pages: 913-919
- DOI
  10.1093/jjco/hyy112
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K09270
[Journal Article] Efficacy and Safety Assessment of Paclitaxel in Patients with Docetaxel-Resistant Esophageal Squamous Cell Carcinoma.2016
- Author(s)
  Imai H, Komine K, Takahashi S, Saijo K, Okada Y, Kobayashi A, Okita A, Chikamatsu S, Kasahara Y, Takahashi M, Oishi T, Shirota H, Takahashi M, Shimodaira H, Ishioka C.
- Journal Title
  
  Chemotherapy
  
  Volume: 61 Issue: 5 Pages: 262-8
- DOI
  10.1159/000444122
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26460958
[Journal Article] Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease2016
- Author(s)
  Kobayashi A, Takahashi M, Imai H, Akiyama S, Sugiyama S, Komine K, Saijo K, Takahashi M, Takahashi S, Shirota H, Sato N, Fujishima F, Shuin T, Shimodaira H, Ishioka C.
- Journal Title
  
  Intern. Med.
  
  Volume: 55 Issue: 6 Pages: 629-634
- DOI
  10.2169/internalmedicine.55.5796
- NAID
  130005138072
- ISSN
  0918-2918, 1349-7235
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25430103, KAKENHI-PROJECT-26460958, KAKENHI-PROJECT-16K07106
[Journal Article] Successful sequential treatment of a patient with advanced gastrointestinal stromal tumor using four different molecularly targeted drugs.2016
- Author(s)
  Sugiyama S, Ishizuka M, Takahashi M, Komine K, Imai H, Saijo K, Takahashi M, Shirota H, Takahashi S, Shimodaira H, Ishioka C.
- Journal Title
  
  International Cancer Conference Journal
  
  Volume: 5 Issue: 4 Pages: 163-7
- DOI
  10.1007/s13691-016-0250-1
- Data Source
  KAKENHI-PROJECT-26460958
[Journal Article] OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer.2016
- Author(s)
  Takahashi M*, Chiba N*, Shimodaira H, Yoshino Y, Mori T, Sumii M, Nomizu T, Ishioka C.
- Journal Title
  
  Breast Cancer
  
  Volume: 24(2) Issue: 2 Pages: 336-340
- DOI
  10.1007/s12282-016-0709-0
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16H04690, KAKENHI-PROJECT-26460958
[Journal Article] Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series.2016
- Author(s)
  Imai H, Shirota H, Okita A, Komine K, Saijo K, Takahashi M, Takahashi S, Takahashi M, Shimodaira H, Ishioka C.
- Journal Title
  
  Chemotherapy
  
  Volume: 61（３） Issue: 3 Pages: 111-116
- DOI
  10.1159/000441551
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25430103, KAKENHI-PROJECT-26460958, KAKENHI-PROJECT-16K07106
[Journal Article] CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.2016
- Author(s)
  Zhang, X.，Shimodaira, H.，Soeda, H.，Komine, K.，Takahashi, H.，Ouchi, K.，Inoue, M.，Takahashi, M.，Takahashi, S.，Ishioka, C.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 21 Issue: 6 Pages: 1091-1101
- DOI
  10.1007/s10147-016-1017-6
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15H04307, KAKENHI-PROJECT-26460958
[Journal Article] DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer.2015
- Author(s)
  Ouchi K, Takahashi S, Yamada Y, Tsuji S, Tatsuno K, Takahashi H, Takahashi N, Takahashi M, Shimodaira H, Aburatani H, Ishioka C.
- Journal Title
  
  Cancer Science
  
  Volume: 106 Issue: 12 Pages: 1722-1729
- DOI
  10.1111/cas.12827
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08962, KAKENHI-PROJECT-26460958, KAKENHI-PROJECT-24221011, KAKENHI-PROJECT-15H04307
[Journal Article] Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer.2015
- Author(s)
  Inoue M, Takahashi S, Soeda H, Shimodaira H, Watanabe M, Miura K, Sasaki I, Kato S, Ishioka C.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 20 Issue: 6 Pages: 1147-55
- DOI
  10.1007/s10147-015-0841-4
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460958, KAKENHI-PROJECT-26461967
[Journal Article] Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia coli Strain.2015
- Author(s)
  Komine K, Shimodaira H, Takao M, Soeda H, Zhang X, Takahashi M, Ishioka C.
- Journal Title
  
  Human Mutation
  
  Volume: 36 Issue: 7 Pages: 704-711
- DOI
  10.1002/humu.22794
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08962, KAKENHI-PROJECT-26460958
[Journal Article] Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801).2014
- Author(s)
  Soeda H., Shimodaira H., Gamoh M., Ando H., Isobe H., Suto T., Takahashi S., Kakudo Y., Amagai K., Mori T., Watanabe M., Yamaguchi T.vKato S., Ishioka C.
- Journal Title
  
  Oncology
  
  Volume: 87 Issue: 1 Pages: 7-20
- DOI
  10.1159/000360989
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26460958
[Journal Article] Clinical usefulness of KRAS, BRAF and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan-and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer2012
- Author(s)
  Soeda, H., Shimodaira, H., Watanabe, M., Suzuki, T., Gamoh, M., Mori, T., Komine, K., Iwama, N., Kato, S., Ishioka, C.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 見逃してはいけない家族性腫瘍;内科領域で見逃しやすい家族性腫瘍2011
- Author(s)
  下平秀樹、西條憲、添田大司、小峰啓吾, 他
- Journal Title
  
  家族性腫瘍
  
  Volume: 11 Pages: 19-22
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 分子標的治療薬におけるバイオマーカーの役割大腸癌における抗EGFR抗体薬のバイオマーカー2011
- Author(s)
  添田大司, 下平秀樹, 石岡千加史
- Journal Title
  
  癌と化学療法
  
  Volume: 38巻7号 Pages: 1079-1083
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 宿主ADCC活性と抗EGFR抗体2010
- Author(s)
  下平秀樹、小峰啓吾、添田大司, 他
- Journal Title
  
  癌と化学療法
  
  Volume: 37 Pages: 795-798
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 進行再発大腸癌における抗EGFR抗体薬の適応宿主ADCC活性と抗EGFR抗体2010
- Author(s)
  下平秀樹, 小峰啓吾, 添田大司, 石岡千加史
- Journal Title
  
  癌と化学療法
  
  Volume: 37 Pages: 795-798
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article]2009
- Author(s)
  下平秀樹、石岡千加史
- Journal Title
  
  がん化学療法・分子標的治療 update(中外医学者)
  
  Pages: 184-188
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] Phase I/II study of sequential therapy with irinotecan and S-1 for meta static colorectal cancer.2009
- Author(s)
  Yoshioka T, Kato S, Gamoh M, Chiba N, Suzuki T, Sakayori N, Kato S, Shibata H, Shimodaira H, et al.
- Journal Title
  
  Br J Cancer 101
  
  Pages: 1972-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 大腸癌における抗EGFR抗体薬と分子マーカーとしてのEGFRを介したシグナル伝達因子2009
- Author(s)
  下平秀樹、添田大司、小峰啓吾, 他
- Journal Title
  
  癌と化学療法 36
  
  Pages: 1063-6
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] 分子標的薬とシグナル伝達大腸癌における抗EGFR抗体薬と分子マーカーとしてのEGFRを介したシグナル伝達因子2009
- Author(s)
  下平秀樹, 添田大司, 小峰啓吾, 石岡千加史
- Journal Title
  
  癌と化学療法
  
  Volume: 36巻7号 Pages: 1063-1066
- Data Source
  KAKENHI-PROJECT-21590802
[Journal Article] Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays2007
- Author(s)
  Takahashi, M., Shimodaira, H., Andreutti-Zaugg, C., Iggo, R., Kolodner, R.D., Ishioka, C
- Journal Title
  
  Cancer Res 67
  
  Pages: 4595-604
- Data Source
  KAKENHI-PROJECT-17015002
[Journal Article] 遺伝性腫瘍研究の現状と将来2005
- Author(s)
  石岡千加史, 千葉奈津子, 酒寄真人, 下平秀樹
- Journal Title
  
  癌と化学療法第32巻
  
  Pages: 962-966
- Data Source
  KAKENHI-PROJECT-16390122
[Presentation] がん薬物療法における最近の進歩2023
- Author(s)
  下平秀樹
- Organizer
  東北医科薬科大学同窓会第39回生涯学習研修会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] コンパニオン診断にて検出されたBRCA1病的バリアントの家系員検査を実施した2家系2023
- Author(s)
  下平秀樹、工藤千枝子、安田勝洋
- Organizer
  東北家族性腫瘍研究会
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] コンパニオン診断にて検出されたBRCA1病的バリアントの家系員検査を実施した2家系2023
- Author(s)
  下平秀樹、工藤千枝子、安田勝洋
- Organizer
  東北家族性腫瘍研究会
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] がん薬物療法における最近の進歩2023
- Author(s)
  下平秀樹
- Organizer
  竹田総合病院　がん医療に関する研修会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] がん薬物療法における最近の進歩2023
- Author(s)
  下平秀樹
- Organizer
  東北医科薬科大学同窓会第39回生涯学習研修会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] がん薬物療法における最近の進歩と課題2023
- Author(s)
  下平秀樹
- Organizer
  鶴岡市立荘内病院研修会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] がん薬物療法における最近の進歩と課題2023
- Author(s)
  下平秀樹
- Organizer
  鶴岡市立荘内病院研修会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] がん薬物療法における最近の進歩2023
- Author(s)
  下平秀樹
- Organizer
  竹田総合病院　がん医療に関する研修会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] 原発不明癌に対しがん薬物療法を行ったPeutz-Jeghers症候群の一例2022
- Author(s)
  下平秀樹,　工藤千枝子, 　安田勝洋, 小峰啓吾, 　髙橋雅信,　石岡千加史
- Organizer
  第28回日本遺伝性腫瘍学会
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] Lynch症候群関連癌におけるがん薬物療法の進歩と今後の展望2022
- Author(s)
  下平秀樹、工藤千枝子、安田勝洋、小峰啓吾
- Organizer
  第28回日本遺伝性腫瘍学会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] 原発不明癌に対しがん薬物療法を行ったPeutz-Jeghers症候群の一例2022
- Author(s)
  下平秀樹,　工藤千枝子, 　安田勝洋, 小峰啓吾, 　髙橋雅信,　石岡千加史
- Organizer
  第28回日本遺伝性腫瘍学会
- Data Source
  KAKENHI-PROJECT-21K07248
[Presentation] Lynch症候群関連癌におけるがん薬物療法の進歩と今後の展望2022
- Author(s)
  下平秀樹、工藤千枝子、安田勝洋、小峰啓吾
- Organizer
  第28回日本遺伝性腫瘍学会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] 多臓器癌に対するNAC　―食道癌など－2021
- Author(s)
  下平秀樹
- Organizer
  第62回日本婦人科学会学術講演会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] Interpreting variants of uncertain significance in hereditary cancer genes in cancer genome era.2019
- Author(s)
  Shimodaira H.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] 既治療の切除不能進行胃癌を対象としたnab-PTXとRAM併用療法における第II相試験の最終解析結果2018
- Author(s)
  高島淳生、坂東英明、下平秀樹、他
- Organizer
  第16回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K09270
[Presentation] Geriatric assessment using G8 screening tool in elderly patients with unresectable or metastatic gastrointestinal cancer2016
- Author(s)
  高橋昌宏、小林輝大、沖田啓、伊藤祝栄、佐藤悠子、高橋信、高橋雅信、城田英和、下平秀樹、石岡千加史
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] A retrospective analysis for efficacy and safety of Gemcitabine plus nab-Paclitaxel in advanced pancreatic cancer2016
- Author(s)
  岡田佳也、小林輝大、大石隆之、西條憲、高橋昌宏、高橋雅信、城田英和、下平秀樹、森隆弘、石岡千加史
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 進行骨軟部肉腫に対するゲムシタビン・ドセタキセル併用療法の効果・安全性に関する後方視的解析2016
- Author(s)
  高橋雅信、岡田佳也、小峰啓吾、今井源、西條憲、高橋昌宏、高橋信、千葉奈津子、森隆弘、下平秀樹、石岡千加史
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 切除不能進行再発大腸癌におけるtrifluridine/tipiracil hydrochlorideとregorafenib投与例の後方視的検討2016
- Author(s)
  笠原佑紀、近松園子、西條憲、小峰啓吾、今井源、高橋昌宏、城田英和、高橋信、高橋雅信、下平秀樹、石岡千加史
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 2.FOLFIRINOX療法およびGEM+nabPTX療法導入後の進行膵癌患者の生存期間の後ろ向き解析2016
- Author(s)
  近松園子，高橋昌宏，山田英晴，沖田啓，小林輝大，佐藤悠子，大内康太，岡田佳也，小峰啓吾，西條憲，今井源，高橋信，高橋雅信，下平秀樹，石岡千加史
- Organizer
  第54回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-20
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] The G8 geriatric screening tool for elderly patients with unresectable or metastatic gastrointestinal cancer2015
- Author(s)
  高橋昌宏、・・、下平秀樹　他
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（北海道、札幌市）
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 治癒切除不能進行膵癌におけるFOLFIRINOX療法の有効性および安全性に関する後方視的検討2015
- Author(s)
  小林輝大、・・、下平秀樹　他
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（北海道、札幌市）
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 小腸癌における5FU系薬剤による治癒成績の後方視的解析2015
- Author(s)
  今井源、・・、下平秀樹　他
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（北海道、札幌市）
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 軟部肉腫に対するドキソルビシン＋イフォスファミド併用療法の治療成績についての後方視的検討2015
- Author(s)
  西條憲、・・、下平秀樹　他
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（北海道、札幌市）
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] 脂肪肉腫の治療薬の臨床開発　オーバービュー2015
- Author(s)
  下平秀樹
- Organizer
  日本肉腫学会記念シンポジウム
- Place of Presentation
  京都平安ホテル（京都府、京都市）
- Year and Date
  2015-12-03
- Invited
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] Phase II intermittent (or stop and go) 1-OHP administration of first-line bevacizumab (BV) plus mFOLFOX6 or CapeOX therapies in Japanese patients with mCRC : The interim report of T-CORE09012012
- Author(s)
  Gamoh, E., Kato, S., Niitani, T., Murakawa, Y., Sakayori, M., Isobe, H., Shimodaira, H., Akiyama, S., Yoshida, K., Yoshioka, T.
- Organizer
  American Society of Clinical Oncology, Gastrointestinal Cancers Symposium 2011
- Place of Presentation
  San Francisco,アメリカ
- Year and Date
  2012-01-20
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the efficacy and safety based on KRAS mutation status (T-CORE0801)2011
- Author(s)
  Shimodaira H., Soeda H., Gamoh H., Andoh T., et.al.
- Organizer
  American Society of Clinical Oncology, Gastrointestinal Cancers Symposium 2011
- Place of Presentation
  San Francisco(USA)
- Year and Date
  2011-01-20
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] EGFR陽性の治癒切除不能な進行再発結腸・直腸癌に対するcetuximabおよび塩酸イリノテカン併用療法のKRAS変異有無による有効性、安全性の前向き試験2011
- Author(s)
  森隆弘、添田大司、蒲生真紀夫、高橋信、角道祐一、天貝賢二、鈴木貴夫、村川康子、加藤誠之、伊藤重豪、渡邊みか、山口拓洋、下平秀樹、加藤俊介、石岡千加史
- Organizer
  第9回日本臨床腫瘍学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2011-07-21
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 石岡千加史:大腸癌におけるEGFRシグナル伝達経路の変異とオキサリプラチン、イリノテカンの治療成績2011
- Author(s)
  添田大司, 下平秀樹, 渡辺みか, 森隆弘, 角道祐一, 高橋信, 秋山聖子, 小峰啓吾, 加藤俊介
- Organizer
  第108回日本内科学会学術講演会
- Place of Presentation
  東京で予定されていた学術講演会は、震災のため開催されず
- Year and Date
  2011-02-20
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 石岡千加史:大腸癌における抗EGFR抗体薬のバイオマーカーEGFRシグナル伝達因子検索の意義2010
- Author(s)
  添田大司, 下平秀樹, 小峰啓吾, 加藤俊介, 森隆弘, 角道祐一, 大堀久詔, 高橋信, 秋山聖子, 鈴木貴夫, 蒲生真紀夫, 渡辺みか, 岩間憲行, 鈴木博義
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 大腸癌における抗EGFR抗体薬のバイオマーカー -EGFRシグナル伝達因子検索の意義-2010
- Author(s)
  添田大司、下平秀樹、小峰啓吾、加藤俊介, 他
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 進行・再発大腸癌におけるcetuximabの治療効果予測因子(KRAS、BRAFおよびPIK3CA遺伝子変異)の解析.2010
- Author(s)
  添田大司, 下平秀樹, 小峰啓吾, 加藤俊介, 森隆弘, 他
- Organizer
  第43回制癌剤適応研究会
- Place of Presentation
  仙台
- Year and Date
  2010-03-12
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 進行・再発大腸癌におけるKRAS、BRAFおよびPIK3CA遺伝子変異解析とcetuximabの治療効果.2010
- Author(s)
  添田大司, 下平秀樹, 小峰啓吾, 加藤俊介, 森隆弘, 他
- Organizer
  第8回日本臨床腫瘍学会学術集会
- Place of Presentation
  東京
- Year and Date
  2010-03-19
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 東北大学病院化学療法カンファレンスの現状と課題2010
- Author(s)
  下平秀樹、森隆弘、角道祐一、高橋信, 他
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Status of EGFR related signal transduction for predicting response to anti-EGFR therapy in advanced colorectal cancer2009
- Author(s)
  Shimodaira, H., Soeda, H., Takahashi, M., Ishioka, C.
- Organizer
  The 68th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  横浜
- Year and Date
  2009-10-01
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 治癒切除不能な進行・再発大腸癌に対しKRASおよびBRAF遺伝子変異解析を行った症例の治療成績の検討.2009
- Author(s)
  添田大司, 下平秀樹, 加藤俊介, 大塚和令, 大堀久詔, 他
- Organizer
  第13回日本がん分子標的治療学会学術集会
- Place of Presentation
  徳島
- Year and Date
  2009-06-26
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 仮説に基づくマーカーと仮説に基づかないマーカー2009
- Author(s)
  石岡千加史, 高橋信, 添田大司, 下平秀樹
- Organizer
  第47回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2009-10-23
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Genetic alterations in colorectal cancer associated with the efficacy of anti-EGFR antibody or cancer predisposition2009
- Author(s)
  Shimodaira, H., Soeda, H., Takahashi, M., Ishioka, C.
- Organizer
  The 14th Korea-Japan Cancer Research Workshop
- Place of Presentation
  金沢
- Year and Date
  2009-12-19
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 3次治療以降でセツキシマブ、イリノテカン併用療法が奏功したKRAS野生型進行直腸癌の2症例.2009
- Author(s)
  西條憲, 加藤俊介, 森隆弘, 下平秀樹, 秋山聖子, 角道祐一, 他
- Organizer
  第36回東北・大腸癌研究会
- Place of Presentation
  福島
- Year and Date
  2009-09-11
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Status of EGFR related signal transduction for predicting response to anti-EGFR therapy in advanced colorectal cancer.2009
- Author(s)
  Shimodaira H., Soeda H., Komine K., Takahashi M., Ishioka C
- Organizer
  68th Annual Meeting of the Japanese Cancer Association International Sessions
- Place of Presentation
  横浜
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Genetic alterations in colorectal cancer associated with the efficacy of anti-EGFR antibody or cancer predisposition.2009
- Author(s)
  Shimodaira, H., Soeda, H., Takahashi, M., et al.
- Organizer
  The 14^<th> Korea-Japan Cancer Research Workshop
- Place of Presentation
  金沢
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] 当院における進行・再発大腸癌に対するKRAS遺伝子解析の実際.2009
- Author(s)
  添田大司, 下平秀樹, 高橋雅信, 小峰啓吾, 加藤俊介, 他
- Organizer
  第47回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2009-10-23
- Data Source
  KAKENHI-PROJECT-21590802
[Presentation] Two cases of breast cancer responding to trastuzumab monotherapy.. Asia Pacific Medical Education Initiative2007
- Author(s)
  Chiba, N., Yoshioka, T., Takahashi, S., Shibata, H., Kato, S., Shimodaira, H., Otsuka, K., Kakudo, Y., Takahashi, M., Yasuda, K., Sakamoto, Y., Ishioka, C
- Organizer
  3rd Asia Pacific Workshop, Molecular targeted Therapy of Cancer
- Place of Presentation
  Shanghai China
- Year and Date
  2007-03-10
- Data Source
  KAKENHI-PROJECT-17015002
[Presentation] Functional evaluation of genetic variants in hereditary colon cancer predispose genes2007
- Author(s)
  Shimodaira, H., Takahashi, M., Ishioka, C
- Organizer
  The 66th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  Yokohama・Pacifico-Yokohama(International Sesseions)
- Year and Date
  2007-10-05
- Data Source
  KAKENHI-PROJECT-17015002
[Presentation] Interaction site of the mismatch repair protein PMS2 with the proapoptotic protein p732006
- Author(s)
  Shimodaira, H., Takahashi, M., Ishioka, C
- Organizer
  The 97th American Association for Cancer Research Annual Meeting
- Place of Presentation
  Washington, DC., USA(poster)
- Year and Date
  2006-04-04
- Data Source
  KAKENHI-PROJECT-17015002
[Presentation] Functional characterization of hMLH1 missense mutations using yeast and in vitro assays2006
- Author(s)
  Takahashi, M., Shimodaira, H., Ishioka, C
- Organizer
  11th International Congress of Human Genetics
- Place of Presentation
  Brisbane, Australia(poster session)
- Year and Date
  2006-08-09
- Data Source
  KAKENHI-PROJECT-17015002
[Presentation] Functional analysis of hMLH1 mutations using yeast and in vitro mismatch repair assays2006
- Author(s)
  Takahashi, M., Shimodaira, H., Kanamaru, R., Ishioka, C
- Organizer
  The 97th American Association for Cancer Research Annual Meeting
- Place of Presentation
  Washington, DC., USA(poster)
- Year and Date
  2006-04-03
- Data Source
  KAKENHI-PROJECT-17015002
[Presentation] CpG island methylator phenotype is associated with the efficacy of chemotherapy for metastatic colorectal cancer
- Author(s)
  張暁飛、下平秀樹、添田大司、小峰啓吾、井上正広、高橋秀和、高橋雅信、高橋信、加藤俊介、石岡千加史
- Organizer
  EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
- Place of Presentation
  Madrid
- Year and Date
  2014-09-26 – 2014-09-30
- Data Source
  KAKENHI-PROJECT-26460958
[Presentation] CpGアイランドメチル化表現型とイリノテカン、オキサリプラチンベースの化学療法の治療成績およびEGFR関連遺伝子変異との相関
- Author(s)
  張暁飛、下平秀樹、添田大司、小峰啓吾、井上正広、高橋秀和、高橋雅信、高橋信、加藤俊介、石岡千加史
- Organizer
  第12回日本臨床腫瘍学会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-26460958
[]

1. ISHIOKA Chikashi (60241577)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
2. KATO Shunsuke (40312657)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. CHIBA Natuko (50361192)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
4. SHIBATA Hiroyuki (50260071)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. TAKAHASHI Masanobu (00447161)

# of Collaborated Projects: 1 results

# of Collaborated Products: 13 results
6. 村川康子 (50250832)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 工藤千枝子 (70816420)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
8. 顧建国 (40260369)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 高橋伸一郎 (40375069)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 中の三弥子 (40397724)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 福田友彦 (40433510)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 山口芳樹 (90323451)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. ZHANG XIAFEI

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
14. SOEDA HIROSHI

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
15. TAKAHASHI Hidekazu

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
16. TAKAHASHI Shin

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. OUCHI Kota

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 城田英和

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
19. 吉野優樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Shimodaira Hideki 下平 秀樹

Hideki Shimodaira 下平 秀樹

SHIMODAIRA Hideki 下平 秀樹

Research Projects

Research Products

Co-Researchers

Elucidation of molecular mechanism for IgG levels regulated by L-fucose

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Functional assay to estimate the significance of variants in CDKN2A gene detected in cancer genome testingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Biological analyses of BRCA1 gene missense variants for application to cancer genome medicinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Significance of CIMP as a biomarker for chemotherapy in colorectal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of predictive marker of drug therapy for colorectal cancer by epigenetic analysis of circulating DNAPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of functional assays for tumor-related genes

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Function of DNA mismatch repair system in the signal transduction of DNA damage responsePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 遺伝性腫瘍学入門 遺伝性腫瘍の基礎知識 「免疫チェックポイント阻害薬」2022

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 遺伝性腫瘍学入門 遺伝性腫瘍の基礎知識 「免疫チェックポイント阻害薬」2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 新臨床腫瘍学（改訂第6版）2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 高齢者がん治療エビデンス＆プラクティス2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 新臨床腫瘍学 がん薬物療法専門医のために 改訂第6版 「遺伝性腫瘍」日本臨床腫瘍学会編2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 高齢者がん治療 エビデンス＆プラクティス「食道がん」2021

Author(s)

Shimodaira Hideki 下平秀樹

Hideki Shimodaira 下平秀樹

SHIMODAIRA Hideki 下平秀樹

[Book] 遺伝性腫瘍学入門　遺伝性腫瘍の基礎知識　「免疫チェックポイント阻害薬」2022

[Book] 遺伝性腫瘍学入門　遺伝性腫瘍の基礎知識　「免疫チェックポイント阻害薬」2021

[Book] 新臨床腫瘍学　がん薬物療法専門医のために　改訂第6版　「遺伝性腫瘍」日本臨床腫瘍学会編2021

[Book] 高齢者がん治療　エビデンス＆プラクティス「食道がん」2021

[Journal Article] 特集　がん領域診療ガイドラインのアップデート　「大腸がん」2021